DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS 
The Alabama Department of Public Health (ADPH) is investigating eleven cases of adverse events associated with ceftriaxone (Rocephin) injections, prompting some physicians in the state to pause prescriptions of this widely-used antibiotic. Although no direct causal relationship has been established between the drug and the reported reactions, healthcare providers are exercising increased vigilance during the ongoing investigation.
Key Points:
- ADPH reports eleven cases of adverse events following ceftriaxone administration, with symptoms suggesting anaphylactic reactions including hives, hypoxia, hypotension, and pruritus
- The investigation remains localized to Alabama, with no comparable incidents reported in other states at this time
- Cephalosporins, including ceftriaxone, typically cause allergic reactions in 0.5% to 2.5% of patients according to ADPH data
- Current evidence shows affected patients presented with various comorbid conditions, complicating the establishment of a direct causal relationship
- ADPH continues to investigate potential epidemiologic links between these events and the administration of ceftriaxone, diluting substances, or concurrent steroid medications
“Just because B follows A, that does not mean that A caused B.”
— Dr. William Schaffner, Vanderbilt University
Antibiotics Summaries